2024 International Congress Archives - Page 71 of 181

Faecal Microbiota Transplant for Parkinson’s Disease: a Phase 1 Pilot Study to Establish Safety and Tolerability

M. de Sciscio, R. Bryant, S. Haylock-Jacobs, A. Day, S. Costello, T. Kimber (Adelaide, Australia)
Fahr’s Disease Presenting as Chorea: A Rare Case Report

DA. Soraya, A. Tiksnadi, D. Tunjungsari (Malang, Indonesia)
Familial Multiple System Atrophy-Mimics: Importance of Comprehensive Evaluation

CH. Jeong, HJ. Kim (Seoul, Republic of Korea)
Fatigue in Parkinson’s Disease: Prevalence and Risk Factors

C. Falup-Pecurariu, I. Murasan, D. Rusu, B. Opritoiu, L. Ungureanu, L. Irincu, I. Despa, S. Diaconu (Brasov, Romania)
Fatigue in PD is related to decreased efficiency of the frontal network

SY. Kang, MS. Kim, S. Park, U. Park, SW. Kang (Hwaseong, Republic of Korea)
Feasibility and added value of sensing feature in patients with chronic STN DBS for Parkinson’s disease

A. Boogers, MB. Justich, M. Montiel, I. Alhashyan, S. Naghdlou, S. Kalia, A. Lozano, RP. Munhoz, A. Fasano (Toronto, Canada)
Feasibility and Comprehensibility of the SMD Decision Tree for Early Recognition of Spasticity

K. Fheodoroff, B. Waeschle, J. Wissel (Hermagor, Austria)
Feasibility and Preliminary Efficacy of a Pilot Telehealth Physical Activity Intervention in Degenerative Cerebellar Disease (Engage-Ataxia)

C. Macpherson, K. Kempner, M. King, S. Kuo, L. Quinn (New York City, USA)
Feasibility of a Web Application to Enable Social Interaction in the PREDICT-PD Cohort

L. Smith, X. Li, A. Gill, P. Panzarasa, J. Bestwick, A. Schrag, A. Noyce, A. de Simoni (London, United Kingdom)
Feasibility of Reliable, Remote Assessment of a 13-year-old Boy Who Stopped Talking

N. Kadubandi, A. Elshourbagy, J. Brašić (Baltimore, USA)
FGF14 repeat expansions: prevalence and case series of patients with SCA27B from Slovakia

M. Ostrozovicova, J. Necpal, D. Pellerin, H. Lee, O. Shabatiuk, K. Kulcsarova, A. Lackova, V. Roth, M. Wandzel, MJ. Dicaire, M. Danzi, V. Han, L. Trckova, S. Zuchner, M. Rizig, H. Houlden, C. Bonnet, M. Renaud, B. Brais, M. Skorvanek (Kosice, Slovakia)
First in vivo evidence of the role of the noradrenergic system in olfactory dysfunction in Parkinson’s disease

C. Laurencin, S. Lancelot, S. Brosse, J. Redouté, I. Mérida, D. Le Bars, N. Costes, S. Thobois, P. Boulinguez, B. Ballanger (lyon, France)
First-In-Human Single and Multiple Ascending Dose Trial Design of LY3962681, a Novel Intrathecally Delivered siRNA Targeting α-synuclein mRNA for the Treatment of Patients with Parkinson’s Disease

T. Lewis, B. Calamini, L. Verselis, M. Lowrey, L. Shaughnessy, J. Deranick, M. Dieter, M. Krautkramer, O. Uspenskaya, J. Sevigny (New York, USA)
Five-Year Changes in MDS-UPDRS-III after Light Treatment (Photobiomodulation)

B. Bicknell, S. Tilley, G. Herkes, A. Liebert (, Westmead, Australia)
Fixel Analysis of Diffusion Imaging in Cerebellar Tracts as a Quantitative Marker of Disease Progression in Spinocerebellar Ataxia

D. Arpin, S. Subramony, D. Vaillancourt, M. Burns (Gainesville, USA)
Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO), A Novel Retinal Mitochondrial Biomarker For Parkinson’s Disease

K. Shivok, E. Affel, M. Alizadeh, T-W. Liang, D. Kremens, R. Sergott (Philadelphia, USA)
Focused ultrasound subthalamotomy in early Parkinson´s disease: three-year prospective follow-up

E. Natera-Villalba, R. Martínez-Fernández, R. Rodríguez-Rojas, M. Del álamo, JA. Pineda-Pardo, I. Obeso, M. Escribano, T. Jiménez Castellanos, C. Gasca-Salas, M. Matarazzo, JA. Obeso (Madrid, Spain)
Focused Ultrasound Thalamotomy for Tremor-Dominant Parkinson Disease – Ablation Volume and Dentatorubrothalamic Tract Overlap Does Not Predict Outcome

J. Peters, J. Maamary, K. Kyle, I. Osborne, N. Olsen, L. Jones, Y. Barnett, B. Jonker, S. Tisch (Darlinghurst, Australia)
Focused Ultrasound Therapy Treatment for Parkinson’s Disease

Z. Muttalib, B. Syed, M. Alam, D. Nadora, U. Ansari, R. Sedighi, A. Vemulapalli, S. Asad (Elk Grove, USA)
Formulations and Assessments of Intra-nasal noses to brain curcumin delivery using reversible nanoparticles for Parkinsonism treatment: A Preclinical Approach

S. Jain (Gandhinagar, India)
Free-living digital mobility outcomes in Parkinson’s disease patients with and without freezing of gait: what can they tell us?

P. Ginis, E. Gazit, C. Schlenstedt, H. Gassner, C. Hansen, A. Mirelman, L. Alcock, C. Becker, J. Aymerich, L. Rivera, C. Kirk, H. Hunter, I. Neatrour, J. Kudelka, H. Hildesheim, P. Goerrissen, M. Gordon, L. Delgado, B. Caulfield, M. Long, M. Gilat, L. Rochester, A. Yarnall, W. Maetzler, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)
Free-Viewing Eye Tracking and the Effect of Levodopa in Parkinson’s Disease

A. Gallagher, H. Elliott, J. Inocentes, C. O'Keeffe, B. Coe, D. Brien, B. White, H. Riek, R. Walsh, T. Lynch, R. Reilly, D. Munoz, C. Fearon (Dublin 7, Ireland)
Free-water MRI Correlates of Pareidolia in Dementia with Lewy Bodies

S. Chiu, R. Chen, W. Wang, G. Smith, B. Boeve, R. Savica, V. Ramanan, J. Fields, N. Graff-Radford, T. Ferman, K. Kantarci, J. Leverenz, N. Armstrong, D. Vaillancourt (Scottsdale, USA)
Frequency of Falls as a Presenti̇ng Symptom and Its Effect i̇n Prognosi̇s i̇n Progressi̇ve Supranuclear Palsy

I. Kamacı, B. Marangozoglu Samanci, B. Zorlu Ucuncuoglu, E. Sahin, B. Bilgin, H. Hanağası (Istanbul, Turkey)
Frequency of LRRK2 p.L1795F variant in Parkinson’s Disease patients from Central Europe within the CEGEMOD consortium

M. Ostrozovicova, G. Tamas, K. Soos, P. Dusek, M. Grofik, V. Han, P. Holly, R. Jech, P. Klivenyi, N. Kovacs, K. Kulcsarova, E. Kurca, A. Lackova, J. Necpal, D. Pinter, E. Ruzicka, T. Serranova, K. Smilowska, I. Straka, T. Svorenova, P. Valkovic, K. Zarubova, H. Houlden, M. Rizig, M. Skorvanek (Kosice, Slovakia)
Frequency of Variants of Uncertain Significance in a Cohort of Early-onset Parkinson’s Disease Patients

A. Zare Dehnavi, C. Piat, N. Niu, O. Ross, A. de Menezes, P. Gaia, R. Savica (Rochester, USA)
Friedreich’s ataxia: A descriptive study of a Tunisian cohort

L. Hlioui, R. Zouari, MZ. Saied, D. Ben Mohamed, A. Rachdi, R. Amouri, S. Ben Sassi (Tunis, Tunisia)
From Images to Insights: Subtyping Parkinson’s Disease Using Unsupervised Learning on MRI Data

D. Teixeira-Dos-Santos, A. De-Oliveira-Franco, A. Bieger, C. Mattjie, F. Suzuki, G. Magalhães Pereira, J. Rossi Catao, L. Angi Souza, L. Silveira Kupssinskü, L. Vinícius Moura, MA. Machado Schlindwein, R. Ravazio, S. Duarte Pinto, T. Hugentobler Schlickmann, E. R. Zimmer, MA. de Bastiani, R. C. Barros, AF. Schumacher Schuh (Porto Alegre, Brazil)
Frontal atrophy in progressive supranuclear palsy[PSP] -an universal feature along with midbrain atrophy?

A. Panwar, A. Prasad, S. Anand (SAS Nagar, India)
Frontal dysfunction as a cognitive biomarker in prodromal Parkinson’s disease

SJM. Jesús Maestre, LMD. Muñoz Delgado, ACG. Castellano Guerrero, MSE. San Eufrasio, AAG. Adarmes Gómez, DMG. Macías García, PFR. Franco Rosado, BV. Villarreal, BB. Benitez, CPC. Perez Calvo, FCG. Carrillo García, JMR. Martín Rodríguez, PMR. Mir Rivera (SEVILLA, Spain)
Frontal Lobe Cortical Thickness and Volumetric Analysis in Parkinson’s Disease Based on Impulse Control Disorder

R. Tripathi, D. Scarisbrick, S. Nkomboni, F. Isbaine, S. Miocinovic, D. Cobia, M. Haut (Atlanta, USA)
Functional Changes Occuring During 10-Week Parkinson’s Disease Group Fitness Classes and Subsequent 8-Week Break

T. Luszeck, C. Young, R. Purcell, K. Hopkinson, M. Timpson (Provo, USA)
Functional Connectivity Changes Associated with Interlimb Coordination Force Deficits in Parkinson’s Disease

A. Bower, J. Chung, R. Burciu (Newark, USA)
Functional connectivity enhances prediction of STN DBS motor outcomes

J. Younce, S. Norris, J. Perlmutter (Chapel Hill, USA)
Functional Motor Disorders in pediatrics: motor patterns and clinical correlates.

V. Baglioni, C. Geroin, D. Esposito, F. Teatini, A. Tessitore, G. Calandra-Buonaura, M. Zibetti, R. Erro, F. Morgante, A. Albanese, F. Bono, M. Zappia, G. Defazio, E. Marcuzzo, A. Sandri, M. Tinazzi (Rome, Italy)
Functional neurological disorders might be a frequent cause of slow orthostatic tremor: insights from a case series.

A. Querejeta-Coma, L. Yupanqui-Guerra, A. Gómez-Domínguez, C. Ordas-Bandera (Móstoles, Spain)
Functionality Analysis of Immunoregulatory Cells Stimulated with Dopaminergic Agonists in People Living with Parkinson’s Disease

AY. Regalado-Mustafá, DD. álvarez-Luquín, A. Guevara-Salinas, MA. Bravo-Martinez, EJ. Gallegos-Altamirano, CF. álvarez-Hernández, E. Ichikawa-Escamilla, AM. Peralta-Maza, V. Morales-Ruiz, EE. Sevilla-Reyes, JI. Velasco-Velázquez, JE. Estudillo-Hernández, M. Rodríguez-Violante, LV. Adalid-Peralta (Mexico City, Mexico)